Open Access. Powered by Scholars. Published by Universities.®
- Keyword
-
- ADSC (1)
- ASC (1)
- Adipose Derived Stem Cells (1)
- Blood-brain barrier (1)
- CNS (1)
-
- Candida albicans (1)
- Central nervous system (1)
- Clinical Trials (1)
- Crocus vernus (1)
- Current Therapies (1)
- Daffodil (1)
- Dandelion (1)
- Invasive mycoses (1)
- Lactoxaseibacillus paracasei (1)
- MS (1)
- MSCs (1)
- Methanol extraction (1)
- Multiple Sclerosis (1)
- Narcissus (1)
- Osmanthus delavyi (1)
- Saccharmocyes cerevisiae (1)
- Staphylococcus epidermidis (1)
- Stem Cell Technology (1)
- Stem Cell Therapy (1)
- Stem Cells (1)
- Taraxum oficinale (1)
- Thin layer chromatography (1)
Articles 1 - 3 of 3
Full-Text Articles in Life Sciences
Regulation Of Mirnas In Obesity And Diabetes, Eva Maher, Ava O'Meara, Cathy Brougham
Regulation Of Mirnas In Obesity And Diabetes, Eva Maher, Ava O'Meara, Cathy Brougham
SURE Journal: Science Undergraduate Research Experience Journal
Introduction: The prevalence of obesity and obesity-related secondary disorders has increased dramatically in recent years. Dysregulated microRNA (miRNA) expression has been linked to the development of obesity and its associated disorders. Adipose derived stem cells (ADSCs) are promising cell models of obesity, obesity-related inflammation and diabetes. Furthermore, miRNA expression profiles have emerged as promising targets for the novel treatment of diseases such as obesity. In order to enhance miRNA-based therapies, the miRNA expression profile of obesity and its related disorders must be monitored to further understand the underlying mechanisms of obesity and to identify novel targets.
Aim: The aim of …
The Potential Of Stem Cell Therapy In Multiple Sclerosis Treatment: A Review, Sorina Amarculesei, Ava O'Meara Cushen, Cathy Brougham
The Potential Of Stem Cell Therapy In Multiple Sclerosis Treatment: A Review, Sorina Amarculesei, Ava O'Meara Cushen, Cathy Brougham
SURE Journal: Science Undergraduate Research Experience Journal
Multiple Sclerosis is an autoimmune and neurodegenerative disease of the central nervous system. There are currently 2.8 million people living with Multiple Sclerosis worldwide, including 9000 people in Ireland, with a prevalence of 193 per 100,000 people. Symptoms of Multiple Sclerosis include sensory loss, fatigue, cognitive dysfunction, spasticity, depression, optic neuritis, gait ataxia, diplopia, and loss of bladder control. Currently, there is no standardised treatment or cure for Multiple Sclerosis with many strategies focusing on symptoms. Stem cells have emerged as promising approaches for Multiple Sclerosis therapeutics. Clinical trials primarily focus on mesenchymal stem cell-based therapies for Multiple Sclerosis. Furthermore, …
Tiny But Mighty, An Exploration Of Microbes And Plants As Sources Of Small Novel Bioactive Compounds Against Invasive Mycoses., Hannah Mai Peacock, James Anthony O'Connor
Tiny But Mighty, An Exploration Of Microbes And Plants As Sources Of Small Novel Bioactive Compounds Against Invasive Mycoses., Hannah Mai Peacock, James Anthony O'Connor
SURE Journal: Science Undergraduate Research Experience Journal
Despite the high mortality rate involved with invasive cerebral mycoses, there is a relative lack of research available around antifungals capable of crossing the blood brain barrier.
In this study the metabolites of four plants (Crocus vernus, Miniature Narcissus (daffodil), Osmanthus delavayi and Taraxacum officinale (common dandelion)) and two bacteria (Lacticaseibacillus paracasei and Staphylococcus epidermidis) were extracted and assayed for antifungal activity against Candida albicans and Saccharomyces cerevisiae. Thin layer chromatography and bioautography were then employed to assess the activity of the constituent components of sources showing antifungal activity.
Metabolites of S.epidermidis, and extracts …